Sajulga, Kice Nhate C.
HRN: 23-16-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/22/2023
06/29/2023
IVTT
85mg
Q24
AGE
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes